Current Humacyte forecasts and price targets in August 2026
Ø Analyst Price Targets
8.01 USD
+1,016.19 %
Median
3.57 USD
+397.21 %
Max
26.25 USD
Min
3.03 USD
Last Price
0.72 USD
Buy
11
Hold
2
Sell
0
The average target price for Humacyte is 8.01 USD. (+1,016.19 % above the current price)
The median price target of Humacyte is 3.57 USD.
Stock analysts from many renowned investment banks are closely examining the Humacyte stock. They conclude their professional Humacyte stock analyses with a clear recommendation for the Humacyte stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-03-01 | 11 | 2 | 0 | — |
| 2026-02-01 | 11 | 2 | 0 | 8.01 USD |
| 2026-02-01 | 11 | 2 | 0 | 7.87 USD |
| 2026-01-01 | 11 | 2 | 0 | 8.01 USD |
| 2025-12-01 | 11 | 2 | 0 | 8.01 USD |
| 2025-12-01 | 11 | 2 | 0 | 8.01 USD |
Humacyte Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Humacyte in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 6.00 M USD | -65.00 M USD | -0.41 USD |
| 2027e | 26.00 M USD | -47.00 M USD | -0.30 USD |
| 2028e | 119.00 M USD | -5.00 M USD | -0.03 USD |